# Sun Life Financial Inc: overview

SLF · NYSE · CIK 1097362 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slf.md) · [Financials](/companies/slf/financials.md) · [Filings](/companies/slf/filings.md) · [Insiders](/companies/slf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [35.7](/filings/0001097362-23-000013.md) | [5.8](/filings/0001097362-24-000007.md) | [40.9](/filings/0001097362-25-000008.md) | [38.8](/filings/0001097362-26-000010.md) | [41.9](/filings/0001097362-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [11.3%](/filings/0001097362-23-000013.md) | [51.0%](/filings/0001097362-24-000007.md) | [7.7%](/filings/0001097362-25-000008.md) | [8.1%](/filings/0001097362-26-000010.md) | [8.5%](/filings/0001097362-26-000010.md) |
| Diluted EPS | $ per share | [6.69](/filings/0001097362-23-000013.md) | [4.89](/filings/0001097362-24-000007.md) | [5.26](/filings/0001097362-25-000008.md) | [5.26](/filings/0001097362-26-000010.md) | [6.15](/filings/0001097362-26-000010.md) |
| Free cash flow | $bn | [(1.9)](/filings/0001097362-23-000013.md) | not reported | [5.4](/filings/0001097362-25-000008.md) | [2.4](/filings/0001097362-26-000010.md) | [2.7](/filings/0001097362-26-000010.md) |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/slf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $3.26bn | 41,552,120 |  | Reduced −95,548 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.26bn | 16,048,272 |  | Added +73,621 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $959.5m | 12,232,736 |  | Added +1,848,886 |
| [TD Asset Management Inc](/funds/1056053.md) | 2026-06-30 | $792.8m | 10,101,426 |  | Reduced −3,921,572 |
| [MACKENZIE FINANCIAL CORP](/funds/919859.md) | 2026-06-30 | $695.3m | 6,244,664 |  | Added +142,127 |
| [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $633.5m | 8,076,018 |  | Reduced −1,240,421 |
| [1832 Asset Management L.P.](/funds/944388.md) | 2026-06-30 | $624.6m | 7,965,126 |  | Reduced −1,098,752 |
| [BANK OF NOVA SCOTIA](/funds/9631.md) | 2026-06-30 | $544.1m | 6,930,024 |  | Added +60,744 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $526.4m | 6,460,912 |  | Added +674,856 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $499.7m | 6,370,400 |  | New +6,370,400 |

## Recent filings

[All 829 filings](/companies/slf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 21:28 ET | [6-K](/filings/0001279569-26-000962.md) | Report of a foreign private issuer, period 2026-10-08 | 0001279569-26-000962 |
| 2026-09-30 | 22:01 ET | [6-K](/filings/0001279569-26-000928.md) | Report of a foreign private issuer, period 2026-09-29 | 0001279569-26-000928 |
| 2026-09-22 | 22:49 ET | [6-K](/filings/0001279569-26-000902.md) | Report of a foreign private issuer, period 2026-09-21 | 0001279569-26-000902 |
| 2026-09-22 | 21:52 ET | [6-K](/filings/0001279569-26-000901.md) | Report of a foreign private issuer, period 2026-09-21 | 0001279569-26-000901 |
| 2026-09-01 | 22:00 ET | [6-K](/filings/0001279569-26-000840.md) | Report of a foreign private issuer, period 2026-08-31 | 0001279569-26-000840 |
| 2026-08-25 | 13:19 ET | [6-K](/filings/0001279569-26-000825.md) | Report of a foreign private issuer, period 2026-08-25 | 0001279569-26-000825 |
| 2026-08-17 | 21:48 ET | [6-K](/filings/0001279569-26-000792.md) | Report of a foreign private issuer, period 2026-08-14 | 0001279569-26-000792 |
| 2026-08-07 | 23:15 ET | [6-K](/filings/0001097362-26-000025.md) | Report of a foreign private issuer, period 2026-06-30 | 0001097362-26-000025 |
| 2026-08-07 | 23:10 ET | [6-K](/filings/0001097362-26-000023.md) | Report of a foreign private issuer, period 2026-06-30 | 0001097362-26-000023 |
| 2026-08-07 | 22:08 ET | [6-K](/filings/0001279569-26-000755.md) | Report of a foreign private issuer, period 2026-08-06 | 0001279569-26-000755 |

## Latest annual report

[Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001097362-26-000010.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1097362
- Tickers: SLF, SLFIF, SLFQF, SUNFF
- Exchange: NYSE
- SIC code: 6311 Life Insurance
- State of incorporation: Z4
- Filer category: not reported

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.
